BioTime Reports Results From Independent Hextend(R) Study
Links shared publicly online about this topic.
- 1,397total visits
BioTime Reports Results From Independent Hextend(R) Study
BioTime, Inc. (NYSE Amex:BTIM) reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch i
View full resource at medicalnewstoday.com
Most Recently Shared on February 8, 2010 at 4:12 pm By:
BioTime Reports Results From Independent Hextend(R) Study http://mnt.to/3xmH #cosmeticmedicine
Advertisement
